chrisvoncsefalvay/vaers-outcomes huggingface dataset:
vasculitis in toes; This spontaneous report was received from a consumer referring to her 18 years old daughter. The patient's concomitant therapy included vitamin d (unspecified). The patient had no pertinent medical history and no drug reactions/allergies.     On an unknown date in August 2020, the patient was vaccinated with the first dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) injection (strength, dose, route, lot number and expiration date were not reported) for prophylaxis. On an unknown date in December 2020 (reported as approximately 2 weeks ago), the patient was vaccinated with the second dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) injection (strength, dose, route, lot number and expiration date were not reported) for prophylaxis.     On an unknown date in December 2020 (reported as approximately 2 weeks ago and a few days later), the patient developed vasculitis in toes. Treatment of unspecified antibiotics was given for the event. There was no lab diagnostics. The outcome of the event was not recovered (reported as worsening). The causality between the event and hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) was not provided.
Breakthrough covid infection on 3/23/22. Patient vaccinated with Pfizer on 1/23/21, 2/13/21, and booster dose on 10/7/2021
States the following morning she had fever, chills, body aches, & nausea. Symptoms lasted 2-3 days.
Head Ache; Stomach Pain; Loss of memory; Loss of appetite; fatigue; Weakness; Sore muscules; I am still sick; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Head Ache), ABDOMINAL PAIN UPPER (Stomach Pain), AMNESIA (Loss of memory), DECREASED APPETITE (Loss of appetite) and FATIGUE (fatigue) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HEADACHE (Head Ache), ABDOMINAL PAIN UPPER (Stomach Pain), AMNESIA (Loss of memory), DECREASED APPETITE (Loss of appetite), FATIGUE (fatigue), ASTHENIA (Weakness), MYALGIA (Sore muscules) and ILLNESS (I am still sick). At the time of the report, HEADACHE (Head Ache), ABDOMINAL PAIN UPPER (Stomach Pain), AMNESIA (Loss of memory), DECREASED APPETITE (Loss of appetite), FATIGUE (fatigue), ASTHENIA (Weakness), MYALGIA (Sore muscules) and ILLNESS (I am still sick) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not provided.  Treatment medications was not given.
pt recv vax 6MAR97 & 5min p/vax pt devel a rapid heartbeat & saw yellow spots;pt recovered from sx 10-15 min p/onset;the day p/vax pt felt fine;
Warm to the touch Left Arm Post first vaccine; Red Left Arm Post first vaccine; Itchy Left Arm Post first vaccine; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Warm to the touch Left Arm Post first vaccine), VACCINATION SITE ERYTHEMA (Red Left Arm Post first vaccine) and VACCINATION SITE PRURITUS (Itchy Left Arm Post first vaccine) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 206M20A and 001B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 13-Feb-2021, the patient experienced VACCINATION SITE WARMTH (Warm to the touch Left Arm Post first vaccine), VACCINATION SITE ERYTHEMA (Red Left Arm Post first vaccine) and VACCINATION SITE PRURITUS (Itchy Left Arm Post first vaccine). On 17-Feb-2021, VACCINATION SITE ERYTHEMA (Red Left Arm Post first vaccine) and VACCINATION SITE PRURITUS (Itchy Left Arm Post first vaccine) had resolved. At the time of the report, VACCINATION SITE WARMTH (Warm to the touch Left Arm Post first vaccine) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medication included anti-itch cream. Concomitant medication not reported.    This case was linked to US-MODERNATX, INC.-MOD-2021-051936 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-051936:2nd dose
Heat at injection site; Fever; Chills; Severe fatigue; Nausea; Swelling at injection site; Muscle pain surrounding injection site to elbow; Tingling from elbow to fingertips; Headache; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: IR8729) via an unspecified route of administration in the arm right on 03May2021 at 09:45 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. Medical history included eosinophilia gastroenteritis, asthma, menorrhagia, dysmenorrhea, arthritis, depression and anxiety. The patient had history of allergies to latex, paper medical tape, various household cleaning agents, green bell pepper. Concomitant medications included duloxetine hydrochloride (CYMBALTA), trazodone (MANUFACTURER UNKNOWN), buspirone (MANUFACTURER UNKNOWN), multivi and ibuprofen (MANUFACTURER UNKNOWN); all from an unknown date for an unknown indication. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the arm right on 10Apr2021 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03May2021 at 10:30, the patient experienced fever, chills, severe fatigue, nausea, headache, heat and swelling at injection site, muscle pain surrounding injection site to elbow, tingling from elbow to fingertips. No therapeutic measures were taken as a result of the reported events. The clinical outcomes of fever, chills, severe fatigue, nausea, headache, heat and swelling at injection site, muscle pain surrounding injection site to elbow, tingling from elbow to fingertips were unknown.   No follow-up attempts are needed. No further information is expected.  Amendment: This follow-up report is being submitted to amend previously reported information: Amended narrative data and added No therapeutic measures were taken as a result of the reported events. and Treatment Received was ticked no for all events.
Patient inadvertently received an extra dose of Twinrix. Denies any adverse symptoms.
On 4/9/2021 - about one hour after vaccine, had difficulty breathing and dizzy. Someone helped her to the car. Had to wait in the car about an hour before she felt well enough to drive. Checked her blood sugar while she was in the car and it was 75 (she had drank half of a Coke.) Usually runs around 200. Otherwise she had usual symptoms, sore swollen arm, fatigue.
Left anterior thigh was red, swollen and with minimal tenderness up to diaper line and 1/2 way down leg. No abscess. Per MD dx'd cellulitis.
no AE; Caller reports vaccine administered after temperature excursion; This spontaneous report has been received from a nurse referring to a patient of unknown gender and age. The patient's medical history, concurrent condition, drug reactions/allergies, and concomitant therapy were not provided.  On 10-MAY-2022, the patient was vaccinated with varicella virus vaccine live (Oka/Merck) (VARIVAX) after temperature excursion 0.5 ml, subcutaneous (SQ) (strength not provided, lot number U024220 has been verified to be a valid lot number, expiration date reported as 03-AUG-2023, but upon internal validation was established as 04-AUG-2023) for prophylaxis (product storage error). The temperature was 10 Fahrenheit with a time frame of 14 minutes. There was no previous temperature excursion. No additional adverse events (no adverse event).
Narrative:  Pt was a 71 YO male with PMH of HTN, arteriosclerosis, cardiomyopathy, PVD, DHF, DM2, HLD, and afib who presented to an hospital with cardiac arrest. Pt subsequently passed away. No evidence that death was caused by COVID-19.
I had my vaccination on 10/14/2022. On 03/18/2023 I had a really bad sore throat fatigue and headache. I tested COVID-19 Negative on 03/19/2023. On 03/22/2023 I was having extreme pain in both legs and I tested COVID-19 Positive. I contacted my physician on 03/22/2023 and they prescribed Paxlovid. I do feel better as of 05/15/2023.
Pain at injection site onset less than 12 hrs post vaccination. Pain lasted 3-4 weeks. No fever, no redness and no swelling. Was seen in ER 2 weeks after injection and diagnosed with cervicalgia (neck and right arm pain).
Took covid shot Thursday 12/17. On Friday 12/18 had avastin shot to right eye. That afternoon had EXTREME inflammation, irritation, tearing, pain and light sensitivity. Vision became "whited out". Saw Dr. sunday 12/20, received two antibiotic shot and steroid shot all to right eye. Prescribed Levaquin po and antibiotic and steroid eye drops. Followed up with retinologist again today 1/4/21, symptoms fairly resolved but vision is still blurry. Hoping to completely regain my sight.
This spontaneous report as received from a registered nurse refers to a patient of unknown demography. Patient's concurrent conditions and relevant medical history was not reported. On 21-JAN-2015, the patient was vaccinated with improperly stored PROQUAD (dose, frequency and route unspecified) (lot number: K011314 with expiry date of 14-FEB-2016). Concomitant medications were not reported. The reporter stated that, between 07-JAN-2015 through 19-FEB-2015, PROQUAD was exposed to 34.4 Fahrenheit temperature which was outside the recommended condition. No adverse effects were reported. The outcome of the events was unknown. The causality of the events with PROQUAD was not reported. Product quality issue was not involved. This is one of the several reports from the same reporter. Additional information has been requested.
fever; warmth; red spot; hardness left arm; A spontaneous report was received from a consumer concerning a herself, who is a 76-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events fever, red spot, hardness left arm, warmth.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 04 Feb 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: 013M20A) intramuscularly for prophylaxis of COVID-19 infection.  On 05 Feb 2021, the patient experienced the events fever, red spot, hardness left arm, warmth.  No treatment details were reported.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of events fever, red spot, hardness left arm, warmth was unknown.
sl warm, very swollen red upper lt arm non-tender from mid arm to shoulder started 36hr p/vax;no redness/swelling noted noc of 17JUN98;
Parent brought child in, she had cellulitis on both legs. R leg was 13x13cm L leg was 13x7cm. Parent had taken child to the hospital on 3/8/08 due to legs swollen and warm to touch. child was placed on Bactrim.
Complete loss of strength in arms and legs. Was unable to get off of the floor for 4 hours.
This spontaneous report as received from a physician refers to a 61 year old female patient. On 27-APR-2013 the patient was vaccinated with ZOSTAVAX, subcutaneous as shingles vaccinations. On 28-Apr-2013, the patient experienced shingles after receiving ZOSTAVAX. The outcome of shingles after receiving ZOSTAVAX is unknown. This is one of two reports received from the same source. Additional information has been requested.
I had tingling numbness; my joints become stiff joints hurt. It started with my shoulder and elbow. I also got COVID-19 in July of 2021. I also have a lamp and elbow and hand.
9/28/2009 5 minutes after injection localized reaction with redness, swelling & blister on injection site. 9/29/2009 Tuesday morning woke up with Lt facial swelling numbness & tingling around L orbital area radiating down side of face to midline of chin. 9/30/09 woke up with more pronounced facial swelling & numbness shoulder & neck pain. 10-1-09 Thursday woke up & facial area & Lt side & tongue numb. Evaluated by Employee Health PAC sent to local MD. He prescribed Prednisone & documented adverse reaction Bell's Palsy.
Extreme  soreness upper left arm  at vaccination  site.     Numbing of hands.    Numbing of  feet area.   Painful  small left toe.
extreme discomfort in left arm. Swelling, redness and hot at injection site-- and entire upper arm. Unable to lift arm more than several inches. Headache, fatigue, malaise, depression and sore throat.
flu like symptoms; This case was reported by a consumer via call center representative and described the occurrence of influenza-like symptoms in a 90-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 25th July 2019, the patient received the 1st dose of Shingrix. On an unknown date, less than 5 months after receiving Shingrix, the patient experienced influenza-like symptoms. On an unknown date, the outcome of the influenza-like symptoms was resolved with sequelae.   It was unknown if the reporter considered the influenza-like symptoms to be related to Shingrix.  Additional details were provided as follows.  The patient reported flu like symptoms after receiving the vaccine. The reporter could not remember much more than what was reported. The reporter did not consent to follow up.
Patient called and said that after receiving her vaccination on Friday 1/21/22, she developed a lump under her armpit.  No "head", about the size of "a small ball"  Patient said it started on Friday and has gotten bigger.  Patient so far has not received treatment.
16 YEAR OLD PATIENT GIVEN MODERNA BOOSTER INSTEAD OF PFIZER BOOSTER.
This spontaneous report as received from a healthcare worker refers to a patient of unknown age and gender. On 08-JUL-2015 the patient was vaccinated with ROTATEQ (dose was not reported, route of vaccination defaulted to oral, lot # K016314 with expiration date: 15-JUN-2016) which was improperly stored. No adverse symptoms reported. This is one of several reports from the same reporter. Additional information has been requested.
2 1/2 yr old given Prevnar on 6/6/01, 6/8/01 started to develop generalized rash. Mother took child to Hosp. Benadryl given. Seen on 6/13/01 referred to ER stat.
Starting ~10PM: fatigue, muscle soreness. Overnight, fever (99.8), chills, aches, Headache, sore throat, fatigue and mild diarrhea.
Pt mother stated pt had an itchy rash the following day after vaccination. Pt described rash as itchy and all over her arms, legs, and torso. that lasted 3 days. Mother stated she gave pt an ointment but could not describe what it was.  Mother did not seek treatment and stated the rash went away after 3 days.
But I am a mother to a 33 month old who still breastfeeds; This spontaneous case was reported by a consumer and describes the occurrence of EXPOSURE VIA BREAST MILK (But I am a mother to a 33 month old who still breastfeeds) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028A21A) for COVID-19 vaccination.    MEDICAL HISTORY (Parent): Concurrent medical conditions included Maternal exposure during breast feeding.    MEDICAL HISTORY (Patient): Concurrent medical conditions included Breast feeding.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage form. On 24-Mar-2021, the patient experienced EXPOSURE VIA BREAST MILK (But I am a mother to a 33 month old who still breastfeeds). At the time of the report, EXPOSURE VIA BREAST MILK (But I am a mother to a 33 month old who still breastfeeds) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No concomitant medication details were provided. No treatment medication information were provided   This case was linked to MOD-2021-105471 (Parent-Child Link).   See case MOD-2021-105471 for details regarding the child case.
Breakthrough COVID-19 infection.  Pt received Pfizer on 5/5/21 and 5/26/21.
myoclonic sz began about 3 wks later & cont to dec rate; benign myoclonus of infancy;
Within 5 hours post vax pt experienced erythema, pain and pruritus at the injection site.  Symptoms resolved without treatment.
Swelling of the deltoid about 5" x 5.5" area is warm. Saw primary care physician day after vaccination when noticed reaction physician prescribed antibiotic and antihistamine.
Pt called the pharmacy and stated she had a rash on her torso.  She was instructed to contact her MD.  She went to the md and they prescribed prednisone and diphenhydramine
13 days after primary Smallpox Vaccine (3 jabs to left deltoid) patient reports to vaccination clinic complaining of lesions on upper body, neck and scalp.  Stated they started 2 days ago and are not painful or itchy.  Otherwise healthy, no other skin complaints.  PE shows 3-4 erythematous 1-2 mm papules and pustules to occipital scalp, acneiform papules on post neck, smallpox vaccine eschar on left shoulder with surrounding erythema, right forearm 2 mm pustule, multiple erythematous papules to chest, few pustules, erythematous papules on abdomen.  No lesions on ear, face, armpits.
12/17/07 Began approx between 8-8:30pm, very fussy, moping around.  Fever began at 9pm.  Temp remains low grade 100 degrees throughout.  Patient still running low grade fever, fussiness at times.
Patient stated that he had arm pain occurring after the immunization and continuing.  He says it gets better some days then worse again.  He says it's sometimes hard to lift his arm.
Persistent soreness  and pain in left upper arm, continuing to date (2 1/2 months after vaccination)
felt heavy feeling all over body by 2AM 15NOV96;went to bed;by that evening , went to ER c/o numbness rt foot, rt hand, rt side face & tingling around mouth;seen by MD;malaise, BP 134/81;Pulse 94;byperventil synd;drowsy, weak, h/a fre
On set atrial fibrillation and kidney function dropped 10 points.  Never had these issues bedore booster.
40 BY 45MM REDNESS AT INJECTION SITE; WARM TO THE TOUCH AND TENDER EXTENDING TO THE SHOULDER.
Vomiting, Diaherria, intussusception 4-5 days post vaccination--tx surgery  (has colostomy bag resulting in 2nd operation in 6-8 weeks). 5/22/07 Received medical records from hospital which reveal patient experienced emesis for 1 day, 3 loose stools w/bloody mucous & abdominal pain.  On admit 5/14/07 was lethargic. FINAL DX: Intusussception, transferred to higher level of care for surgery. 5/29/07 Received hospital medical records which reveal patient was received from outlying hospital after vomiting, bloody diarrhea, pallor & lethargy.  Admitted 5/14-5/18/07.  Unable to reduce the IS & was taken to OR for exp lap & resection of sholecolonic IS, colostomy & placement of central line.  26 cm of colon was removed & patient was in ICU post op, intubated & on multiple IV antibiotics.  Initially on TPN but was able to be extubated & diet advanced to oral FINAL DX: Cholecolonic intussusception; intussusception nonreducible, w/perforation.  Follow-up: He will always have the risk of bowel obstruction and other bowel conditions due to the intensity of the surgeries.
On the day after the injection, a boil appeared on my elbow.  The boil was like a blister without any pain, no redness, nothing.  Just like a big (20 cc) ball of lymph (I suppose it is lymph). I am a long-term survivor of COVID19.  I believe (have no proof) that I got it last January at the Chinese New Year Party.  I felt sick some 10 or 15 days later.  At the time, I thought that my vertebrae have unfused and barely could move.  Little by little improved, but then lymph accumulated in my body. The lymph would go into the muscles and make every move to be painful. My health degenerated until July 31st. I gained weight. At the time, doctors knew nothing and my self-diagnosis was that I could have blood clots. On July 31st, I changed the diagnosis for generalized inflammation.  I treated the generalized inflammation with exercise considering that the inflation was proportional to the fat in my body.  It worked. I am now 21 lbs lighter and better. That is when I received this new vaccine.  The boil is not unexpected, considering the history.
p/vax pt upper arm began to swell;it also became indurated & erythematous;pt had some dec mobility in the arm & trouble sleeping, all d/t the pain;called 8/10/99 AM & was seen ;area of induration & erythema;improved from noc a/;T100.5 ear
Hives occurring almost daily lasting 30 min to 1 hour. Exacerbated by cold temperature. Diffuse, itchy.
Developed tinnitus (ringing in the ears) within 3 days of 2nd shot.
Subcutaneous lump at injection site began day after injection. Only painful if touched. Mild itching. Second day after vaccine the lump had decreased in size.
high fever; headache; chills; body aches; nausea; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (high fever), HEADACHE (headache), CHILLS (chills), PAIN (body aches) and NAUSEA (nausea) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (high fever), HEADACHE (headache), CHILLS (chills), PAIN (body aches) and NAUSEA (nausea). At the time of the report, PYREXIA (high fever), HEADACHE (headache), CHILLS (chills), PAIN (body aches) and NAUSEA (nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No concomitant medications were provided.  No treatment details were provided.
bruising at injection site; itching at the injection site; Swelling at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of   in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported.).    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No concomitant medications reported. No treatment information provided.
Patient got 1st dose Moderna at Medical center 3-23-21.On 8-6-21 pt got 1st dose pfizer at Pharmacy.Pt stated on consent form:never received any covid vaccine.Pt wanted 2nd dose pfizer 9-21-21.Check CAIR and found out pt got moderna (Medical center) and pfizer (pharmacy)
Patient had an injection reaction. A day after the reaction she had welpy bumps around the injection that were itchy. The next day they were not itchy, just sore.
This spontaneous report as received from a Licensed Practical Nurse. On 24-MAY-2013, multiple unspecified patients were vaccinated with VAQTA (lot # 0273AE exp. 06-DEC-2014 and lot # H012669, exp. 17-APR-2015). The nurse reported the dose of VAQTA were exposed to 30.1 degrees Fahrenheit for three hours, which was unsupported by stability data. No adverse effects reported. This is one of several cases received from same source. Additional information has been requested.
Flushing, Nausea, Dizziness, Shortness of breath, Difficulty standing /sitting up. Occurred immediately after vaccine (about 1-2mins). Given Zofran 4mg SL and Benadryl 25mg. EpiPen was available for use but not needed. EMTs were alerted.